KWWL Mad Money November 24, 2015
Botox, which they havent raised the price up, while simultaneously keeping up with new uses for the darn thing, past wrinkles and migraines. Perhaps they can run into a new form of company with this merger and the cash flow they had. Thats what the hope is. In the meantime youre being paid to wave dividends that nets 3. 5 . The market doesnt like this. Absolutely doesnt like this deal. For real allergan shareholders because its delighted with phaser before it closes. And potential government challenge over the tax avoidance scheme. We believed in Brett Saunders aspirational earnings estimate. ...
Source: archive.org